Business Wire | Jan 3, 2022 04:30PM EST

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference

Jan. 03, 2022

BAUDETTE, Minn.--(BUSINESS WIRE)--Jan. 03, 2022--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:

Date: Monday, January 10, 2022

On Demand: 7:00 a.m. ET

Webcast: https://journey.ct.events/view/ 5e7687b5-9c3a-4a19-b96c-88ad184d5c59

The webcast will be accessible on demand beginning on January 10, 2022, at 7:00 a.m. ET and archived for 90 days thereafter, via the Company's website at www.anipharmaceuticals.com, under the Investors section.

About ANI

ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin(tm) Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220103005452/en/

CONTACT: Investor Relations: Lisa M. Wilson, In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com

CONTACT: Media: Angela Salerno-Robin dna Communications T: 212-445-8219 E: ASalerno-Robin@dna-comms.com